Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Quinapril hydrochloride equivalent to 5 mg, 10 mg, 20 mg quinapril Tablets Godecke AG, Freiburg, Germany and Parke Davis, Orleans Cedex, France Accupril Hepatitis B virus vaccine inactivated 10g in 0.5 mL, 20g in 1 mL Injection, solution SmithKline Beecham Biologicals Manufacturing, Rixensart, Belgium Engerix-B Saquinavir 200 mg Capsule, soft gelatin R P Scherer GmbH., Eberbach/Baden, Germany Fortovase Lenograstim 13.4MIU Injection, powder Chugai Pharmaceutical Co Limited, Utsunomiya, Tochigi, Japan Granocyte 13 Lenograstim 33.6MIU Injection, powder Chugai Pharmaceutical Co Limited, Utsunomiya, Tochigi, Japan Granocyte 34 Paclitaxel 6 mg/mL Infusion, concentrate Bristol-Caribbean Inc., Mayaguez, Puerto Rico Taxol Dated this 31st day of January 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.